Photo of Tom Powles taken from bartscancer.london
May 26, 2024, 11:15
Tom Powles: 3 renal cancer biomarker orals at ASCO24
Tom Powles, Director of Barts Cancer Center, shared on X/Twitter:
“3 renal cancer biomarker orals at ASCO24 (Len/pem vs sun, axi/pem vs sun, atezo vs placebo). DNA, RNA, protein and blood (KIM1) data. .
Below is a summary of progress to date. Will this change or is it more exploratory data with problems more than solutions? Do 151RNA signatures have a future?”
Source: Tom Powles/X